Gut, hiperüremi ve Parkinson hastalığı arasındaki ilişki: sistematik bir inceleme ve meta-analiz.
Association between gout, hyperuricemia, and Parkinson's disease: a systematic review and meta-analysis.
DOI: 10.1186/s40001-025-03202-1PMID: 41024289
Association between gout, hyperuricemia, and Parkinson's disease: a systematic review and meta-analysis.
DOI: 10.1186/s40001-025-03202-1PMID: 41024289
Advancing the sensori-/psychomotor domain in schizophrenia spectrum disorders: From clinical observation to translational innovation.
DOI: 10.1016/j.schres.2025.09.021PMID: 41027081
Unraveling synucleinopathies: Recent breakthroughs in Parkinson's disease therapy.
DOI: 10.1016/j.jpet.2025.103735PMID: 41135411
Parkinsonism-Hyperpyrexia Syndrome Following Deep Brain Stimulation Battery Depletion during the COVID-19 Pandemic: A Case Series and Review of the Literature.
DOI: 10.1002/mdc3.70320PMID: 41017701
Structure and function of voltage-gated sodium channel Nav1.6: Involvement in the pathological process of neural injury.
DOI: 10.4103/nrr.nrr-d-25-00354PMID: 41017705
Akkermansia muciniphila : A next-generation gut probiotic supporting neurorepair and functional recovery.
DOI: 10.4103/nrr.nrr-d-25-00701PMID: 41017717
Exploring the Effectiveness of Immersive Virtual Reality Rehabilitation for Parkinson's Disease: A Narrative Review.
DOI: 10.3390/jcm14196858PMID: 41095938
Melatonin-Mediated Nrf2 Activation as a Potential Therapeutic Strategy in Mutation-Driven Neurodegenerative Diseases.
DOI: 10.3390/antiox14101190PMID: 41154499
BPC 157 Therapy: Targeting Angiogenesis and Nitric Oxide's Cytotoxic and Damaging Actions, but Maintaining, Promoting, or Recovering Their Essential Protective Functions. Comment on Józwiak et al. Multifunctionality and Possible Medical Application of the BPC 157 Peptide-Literature and Patent Review. <i>Pharmaceuticals</i> 2025, <i>18</i>, 185.
DOI: 10.3390/ph18101450PMID: 41155565
Roles and therapeutic potential of PARP-1 in neurodegenerative diseases.
DOI: 10.1016/j.bcp.2025.117373PMID: 41022359
Galectin-3 as a Key Driver of Neuroinflammation and α-Synuclein Aggregation in Parkinson's Disease: Unlocking New Paths for Biomarkers and Therapies.
DOI: 10.1007/s12013-025-01875-3PMID: 41014450
The association between anosognosia and neuropsychiatric symptoms in neurodegenerative dementias: a narrative review.
DOI: 10.3389/fneur.2025.1649627PMID: 41079349
Kayıtlar bilimsel kaynaklardan alınır. Bibliyografik kayıt sayısı, Türkçe çeviri veya editoryal onay sayısı değildir.